3.82  0.37 (10.72%)		01-15 16:00
Open: 3.48 High: 3.91 Volume: 101,666		Pre. Close: 3.45 Low: 3.45 Market Cap: 26(M)

Short term
Mid term
Targets	6-month :	5.14	1-year :	5.95
Resists	First :	4.4	Second :	5.09
Pivot price	4.02
Supports	First :	3.26	Second :	2.72
MAs	MA(5) :	3.52	MA(20) :	4.17
	MA(100) :	3.21	MA(250) :	2.7
MACD	MACD :	-0.1	Signal :	0
%K %D	K(14,3) :	19.6	D(3) :	13.5
RSI	RSI(14): 48.8
52-week	High :	5.09	Low :	1.84

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ NXGL ] has closed above bottom band by 40.5%. Bollinger Bands are 156.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 21 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	3.91 - 3.94	3.94 - 3.96
Low:	3.4 - 3.43	3.43 - 3.45
Close:	3.78 - 3.83	3.83 - 3.86

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

Thu, 02 Jan 2025
NEXGEL Appoints Veteran Financial Executive Joseph McGuire as New CFO Amid Growth Phase - StockTitan

Thu, 21 Nov 2024
NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024 - GlobeNewswire

Thu, 14 Nov 2024
Analysts Expect Breakeven For NEXGEL, Inc. (NASDAQ:NXGL) Before Long - Simply Wall St

Wed, 13 Nov 2024
NEXGEL, Inc. Announces Third Quarter 2024 Financial Results Release and Conference Call - MyChesCo

Wed, 13 Nov 2024
NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 - GlobeNewswire

Mon, 11 Nov 2024
NEXGEL to Report Third Quarter 2024 Financial Results on November 13th - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	7 (M)
Shares Float	5 (M)
Held by Insiders	20 (%)
Held by Institutions	2.9 (%)
Shares Short	26 (K)
Shares Short P.Month	31 (K)

EPS	-0.59
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.81
Profit Margin	-67.6 %
Operating Margin	-73.2 %
Return on Assets (ttm)	-23.2 %
Return on Equity (ttm)	-64.4 %
Qtrly Rev. Growth	23.3 %
Gross Profit (p.s.)	0
Sales Per Share	0.73
EBITDA (p.s.)	-0.51
Qtrly Earnings Growth	0 %
Operating Cash Flow	-3 (M)
Levered Free Cash Flow	-2 (M)

PE Ratio	-6.48
PEG Ratio	0
Price to Book value	4.65
Price to Sales	5.17
Price to Cash Flow	-8.37

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.